Lu Y F, Santostefano M, Cunningham B D, Threadgill M D, Safe S
Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station 77843-4466.
Arch Biochem Biophys. 1995 Jan 10;316(1):470-7. doi: 10.1006/abbi.1995.1062.
The competitive binding of 3'-methoxy-4'-nitro, 4'-amino-3'-methoxy, 4'-methoxy-3'-nitro, and 3'-amino-4'-methoxyflavone (compounds 1 to 4, respectively) to the rat cytosolic aryl hydrocarbon (Ah) receptor gave IC50 values of 2.27, 86.1, 872, and 19.4 nM. Flavones 3 and 4 were characterized as Ah receptor agonists in MCF-7 human breast cancer cells and induced CYP1A1 gene expression, whereas the 3-methoxy-substituted flavones (1 and 2) were inactive. All four compounds inhibited induction of ethoxyresorufin O-deethylase (EROD) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells; moreover, in vitro studies with TCDD-induced rat liver microsomes showed that flavones 1 to 4 inhibited EROD activity in the presence or absence of NADPH. In MCF-7 cells cotreated with flavones 1 or 2 (0.01 to 10 microM) plus TCDD or [3H]TCDD, there was a concentration-dependent inhibition of TCDD-induced CYP1A1 mRNA levels and formation of radiolabeled nuclear Ah receptor complex. Velocity sedimentation analysis of nuclear extracts from MCF-7 cells treated with [3H]TCDD plus 1 or 10 microM concentrations of flavones 1 and 2 showed that an early eluting specifically bound nuclear Ah receptor complex was present. However, under these same conditions the flavones inhibited TCDD-induced CYP1A1 gene expression. The apparent molecular mass of this nuclear complex was 190 kDa as determined by cross-linking to a 32P-labeled bromodeoxyuridine-substituted consensus dioxin-responsive element. Similar cross-linking results were obtained using the nuclear extract from MCF-7 cells treated with [3H]TCDD alone. The results of this study suggest that there are at least two forms of the nuclear Ah receptor complex in MCF-7 cells; the major transcriptionally active form binds [3H]TCDD and flavones 1 or 2 inhibit nuclear uptake of this receptor complex. The other form of the nuclear Ah receptor complex appears to be transcriptionally inactive and ligand binding with [3H]TCDD is not competitively inhibited by flavones 1 and 2.
3'-甲氧基-4'-硝基黄酮、4'-氨基-3'-甲氧基黄酮、4'-甲氧基-3'-硝基黄酮和3'-氨基-4'-甲氧基黄酮(分别为化合物1至4)与大鼠胞质芳烃(Ah)受体的竞争性结合的半数抑制浓度(IC50)值分别为2.27、86.1、872和19.4 nM。黄酮3和4在MCF-7人乳腺癌细胞中被鉴定为Ah受体激动剂,并诱导CYP1A1基因表达,而3-甲氧基取代的黄酮(1和2)则无活性。所有四种化合物均抑制2,3,7,8-四氯二苯并-对-二恶英(TCDD)在MCF-7细胞中诱导的乙氧基异吩恶唑酮-O-脱乙基酶(EROD)活性;此外,对TCDD诱导的大鼠肝微粒体进行的体外研究表明,黄酮1至4在有无烟酰胺腺嘌呤二核苷酸磷酸(NADPH)的情况下均抑制EROD活性。在与黄酮1或2(0.01至10 microM)加TCDD或[3H]TCDD共同处理的MCF-7细胞中,TCDD诱导的CYP1A1 mRNA水平和放射性标记的核Ah受体复合物的形成呈浓度依赖性抑制。对用[3H]TCDD加1或10 microM浓度的黄酮1和2处理的MCF-7细胞核提取物进行速度沉降分析表明存在一种早期洗脱的特异性结合核Ah受体复合物。然而,在相同条件下,黄酮抑制TCDD诱导的CYP1A1基因表达。通过与32P标记的溴脱氧尿苷取代的共有二恶英反应元件交联测定,该核复合物的表观分子量为190 kDa。使用仅用[3H]TCDD处理的MCF-7细胞核提取物也获得了类似的交联结果。本研究结果表明,MCF-7细胞中至少存在两种形式的核Ah受体复合物;主要的转录活性形式结合[3H]TCDD,黄酮1或2抑制该受体复合物的核摄取。核Ah受体复合物的另一种形式似乎无转录活性,黄酮1和2不会竞争性抑制其与[3H]TCDD的配体结合。